Divarasib outperforms first-generation KRAS-G12C inhibitors in NSCLC.
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.
Journals this month
Topics moving, week to 17 Nov 2026
By field